CLICS Archive
Dashboard
Bill Archiver
Bill Runs
Bill Archives
Bills
Schedules
Schedule Runs
Schedules
Committees
Committee Runs
Committees
Meeting Runs
Meetings
Legislators
Legislator Runs
Legislators
CF Tester
Settings
Back to Archives
Archive #38963
Metadata
Bill Number
SB26-066
HTTP Status
200
Valid JSON
Valid
Archived At
2026-03-03 15:12:00 MST
Created At
2026-03-03 15:12:00 MST
Parsed JSON
{ "votes": [], "active": "T", "origin": "Senate", "lls_num": "26-0540", "session": "2026A", "subject": [ "Civil Law", "Public Health" ], "bill_num": "SB26-066", "sponsors": [ { "id": "IJ001", "title": "Senator", "s_type": "Prime Sponsor", "chamber": "Senate", "full_name": "Iman Jodeh", "last_name": "Jodeh", "first_name": "Iman", "sponsor_order": "1" }, { "id": "JC004", "title": "Senator", "s_type": "Prime Sponsor", "chamber": "Senate", "full_name": "John Carson", "last_name": "Carson", "first_name": "John", "sponsor_order": "2" } ], "bill_files": [ { "url": "https://www.leg.state.co.us/CLICS/CLICS2026A/csl.nsf/0/D48F126F849D246787258D49006A35B9/$File/066_01.pdf", "date": "01/28/2026", "label": "Introduced", "url_html": "https://www.leg.state.co.us/CLICS/CLICS2026A/csl.nsf/0/D48F126F849D246787258D49006A35B9/$File/066_01.html", "lastModified": "01/28/2026 12:26:00 PM" } ], "committees": [ { "id": "S_HHS_2026A", "name": "Health & Human Services", "chamber": "Senate" } ], "long_title": "Concerning the regulation of compounded weight-loss medications that have not been approved by the United States food and drug administration.", "bill_status": "In Committee - SEN Health & Human Services", "short_title": "Regulation of Compounded Weight-Loss Medication", "bill_summary": "<html><body><p><t></t></p><p>The bill establishes regulations for the sale, transfer, or distribution of compounded weight-loss medications, which are custom-made medications that, unlike mass-produced medications, are not subject to approval by the federal food and drug administration (FDA). A person may not sell, transfer, or distribute a compounded weight-loss medication unless the person confirms that the medication:</p><p><ul><li>Is made from bulk drug substances and drugs that are approved by the FDA when such approval is required;<li>Was manufactured in compliance with FDA processes; <li>Contains bulk drug substances that are pharmaceutical grade and are accompanied by a certificate of analysis containing information that is material to the safety and efficacy of the bulk drug substances;<li>Was manufactured at a facility that is registered with the FDA and passed an FDA inspection within the previous 2 years; and<li>Is verified for purity and accurate dosage.</li></ul><t></t></p><p>Labels for compounded weight-loss medications must list all active and inactive ingredients, the quantity of those ingredients, and the ingredients' country of origin. There must also be a warning on the label stating that the compounded weight-loss medication has not been FDA-approved, has inadequate evidence of safety or efficacy, and has known and unknown side effects. A person must also provide certain disclosures to a patient when prescribing compounded weight-loss medications.</p><p><t></t></p><p>The bill prohibits the use of false or misleading claims, including unsubstantiated claims, when advertising or promoting compounded weight-loss medications.</p><p><t></t></p><p>A person that sells, transfers, or distributes compounded weight-lost medication must keep records related to the compounded weight-loss medication for at least 2 years after the date of expiration of the compounded weight-loss medication and make those records available for inspection by the state board of pharmacy.</p><p><t></t></p><p>The state board of pharmacy may issue fines of up to $1,000 per dose of compounded weight-loss medications that are sold or distributed in violation of the bill and may revoke a pharmacy or business license for violations.</p><p><t></t></p><p>The attorney general has authority to enforce this bill as a deceptive trade practice under the "Colorado Consumer Protection Act".</p><p><br/><i>(Note: This summary applies to this bill as introduced.)</i></p></body></html>", "progress_bar": [ { "end": "F", "label": "Introduced", "position": 1 }, { "end": "F", "label": "Under Consideration", "position": 2 } ], "special_type": "", "bill_category": "Consumer & Commercial Transactions", "allow_testimony": "F", "amendment_files": [], "full_bill_topic": "Regulation of Compounded Weight-Loss Medication", "long_bill_files": [], "GHG_report_files": [], "preamended_files": [], "bill_sub_category": "Consumer Protection", "fiscal_note_files": [ { "url": "https://www.leg.state.co.us/CLICS/CLICS2026A/csl.nsf/0/D48F126F849D246787258D49006A35B9/$File/SB066_00.pdf", "date": "03/03/2026", "label": "FN1", "url_html": "", "lastModified": "03/03/2026 03:05:08 PM", "label_detailed": "Initial Fiscal Note" } ], "is_budget_package": "No", "session_laws_files": "", "summarized_history": [ { "date": "01/28/2026", "action": "Introduced In Senate - Assigned to Health & Human Services", "location": "Senate" } ], "research_note_files": [], "bill_sub_sub_category": "Other", "committee_report_files": [], "demographic_note_files": [], "updated_bill_summary_files": [], "budget_staff_analysis_files": [], "first_chamber_third_reading_date": "", "second_chamber_third_reading_date": "" }
Raw Response
{"bill_num":"SB26-066","lls_num":"26-0540","origin":"Senate","short_title":"Regulation of Compounded Weight-Loss Medication","full_bill_topic":"Regulation of Compounded Weight-Loss Medication","long_title":"Concerning the regulation of compounded weight-loss medications that have not been approved by the United States food and drug administration.","special_type":"","bill_category":"Consumer & Commercial Transactions","bill_sub_category":"Consumer Protection","bill_sub_sub_category":"Other","is_budget_package":"No","subject":["Civil Law","Public Health"],"bill_status":"In Committee - SEN Health & Human Services","sponsors":[{"id":"IJ001","title":"Senator","first_name":"Iman","last_name":"Jodeh","full_name":"Iman Jodeh","s_type":"Prime Sponsor","chamber":"Senate","sponsor_order":"1"},{"id":"JC004","title":"Senator","first_name":"John","last_name":"Carson","full_name":"John Carson","s_type":"Prime Sponsor","chamber":"Senate","sponsor_order":"2"}],"committees":[{"id":"S_HHS_2026A","chamber":"Senate","name":"Health & Human Services"}],"first_chamber_third_reading_date":"","second_chamber_third_reading_date":"","summarized_history":[{"date":"01/28/2026","location":"Senate","action":"Introduced In Senate - Assigned to Health & Human Services"}],"progress_bar":[{"position":1,"label":"Introduced","end":"F"},{"position":2,"label":"Under Consideration","end":"F"}],"active":"T","session":"2026A","allow_testimony":"F","long_bill_files":[],"bill_files":[{"date":"01/28/2026","lastModified":"01/28/2026 12:26:00 PM","label":"Introduced","url":"https://www.leg.state.co.us/CLICS/CLICS2026A/csl.nsf/0/D48F126F849D246787258D49006A35B9/$File/066_01.pdf","url_html":"https://www.leg.state.co.us/CLICS/CLICS2026A/csl.nsf/0/D48F126F849D246787258D49006A35B9/$File/066_01.html"}],"fiscal_note_files":[{"date":"03/03/2026","lastModified":"03/03/2026 03:05:08 PM","label":"FN1","label_detailed":"Initial Fiscal Note","url":"https://www.leg.state.co.us/CLICS/CLICS2026A/csl.nsf/0/D48F126F849D246787258D49006A35B9/$File/SB066_00.pdf","url_html":""}],"research_note_files":[],"budget_staff_analysis_files":[], "preamended_files":[],"committee_report_files":[],"updated_bill_summary_files":[],"demographic_note_files":[],"GHG_report_files":[],"bill_summary":"<html><body><p><t></t></p><p>The bill establishes regulations for the sale, transfer, or distribution of compounded weight-loss medications, which are custom-made medications that, unlike mass-produced medications, are not subject to approval by the federal food and drug administration (FDA). A person may not sell, transfer, or distribute a compounded weight-loss medication unless the person confirms that the medication:</p><p><ul><li>Is made from bulk drug substances and drugs that are approved by the FDA when such approval is required;<li>Was manufactured in compliance with FDA processes; <li>Contains bulk drug substances that are pharmaceutical grade and are accompanied by a certificate of analysis containing information that is material to the safety and efficacy of the bulk drug substances;<li>Was manufactured at a facility that is registered with the FDA and passed an FDA inspection within the previous 2 years; and<li>Is verified for purity and accurate dosage.</li></ul><t></t></p><p>Labels for compounded weight-loss medications must list all active and inactive ingredients, the quantity of those ingredients, and the ingredients' country of origin. There must also be a warning on the label stating that the compounded weight-loss medication has not been FDA-approved, has inadequate evidence of safety or efficacy, and has known and unknown side effects. A person must also provide certain disclosures to a patient when prescribing compounded weight-loss medications.</p><p><t></t></p><p>The bill prohibits the use of false or misleading claims, including unsubstantiated claims, when advertising or promoting compounded weight-loss medications.</p><p><t></t></p><p>A person that sells, transfers, or distributes compounded weight-lost medication must keep records related to the compounded weight-loss medication for at least 2 years after the date of expiration of the compounded weight-loss medication and make those records available for inspection by the state board of pharmacy.</p><p><t></t></p><p>The state board of pharmacy may issue fines of up to $1,000 per dose of compounded weight-loss medications that are sold or distributed in violation of the bill and may revoke a pharmacy or business license for violations.</p><p><t></t></p><p>The attorney general has authority to enforce this bill as a deceptive trade practice under the "Colorado Consumer Protection Act".</p><p><br/><i>(Note: This summary applies to this bill as introduced.)</i></p></body></html>","amendment_files":[],"session_laws_files":"","votes":[]}